SCHEMBL23332069

SCHEMBL23332069

C/C(=N\NC(=O)CC(C)(C)C)c1ccc(C)cc1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.58
▸ ALDH1A1 P00352 3/20 0.57
▸ MAPT P10636 3/20 0.57
▸ KMT2A Q03164 3/20 0.53
▸ MEN1 O00255 2/20 0.53
▸ LMNA P02545 2/20 0.53
▸ HTT P42858 1/20 0.53
▸ GFER P55789 2/20 0.47
▸ TP53 P04637 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ POLB P06746 2/20 0.47
▸ ESRRG P62508 1/20 0.47
▸ PKM P14618 1/20 0.47
▸ MAPK1 P28482 1/20 0.45
▸ GAA P10253 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22214478 0.77 MAPT (0.54) SMN1; SMN2ALDH1A1MAPTKMT2AMEN1
SCHEMBL27177939 0.76 ESRRG (0.78) SMN1; SMN2ALDH1A1MAPTKMT2AMEN1
SCHEMBL27177945 0.76 ESRRG (0.78) SMN1; SMN2ALDH1A1MAPTKMT2AMEN1
SCHEMBL20080851 0.76 LMNA (0.72) SMN1; SMN2ALDH1A1MAPTKMT2AMEN1
SCHEMBL21052062 0.76 MAPT (0.58) SMN1; SMN2ALDH1A1MAPTKMT2AMEN1
SCHEMBL21052063 0.76 MAPT (0.58) SMN1; SMN2ALDH1A1MAPTKMT2AMEN1
SCHEMBL14616550 0.76 MAPT (0.53) SMN1; SMN2ALDH1A1MAPTKMT2AMEN1
SCHEMBL24086403 0.73 MAPT (0.50) SMN1; SMN2ALDH1A1MAPTKMT2AMEN1
SCHEMBL27178213 0.72 SMN1; SMN2 (0.74) SMN1; SMN2ALDH1A1MAPTKMT2AMEN1
SCHEMBL27178327 0.72 SMN1; SMN2 (0.74) SMN1; SMN2ALDH1A1MAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021087368-A2 ANTI-CD45 ANTIBODIES AND CONJUGATES THEREOF Magenta Therapeutics, Inc. (US) 2021-05-06 — — WO disclosed
Send feedback